333 related articles for article (PubMed ID: 34298907)
21. Disappearance of the inhibitory effect of neuropeptide Y within the dorsolateral bed nucleus of the stria terminalis in rats with chronic pain.
Hara R; Asaoka Y; Takahashi D; Nomura H; Amano T; Minami M
Neurosci Lett; 2020 May; 728():134958. PubMed ID: 32278943
[TBL] [Abstract][Full Text] [Related]
22. Regional distribution of putative NPY Y1 receptors and neurons expressing Y1 mRNA in forebrain areas of the rat central nervous system.
Larsen PJ; Sheikh SP; Jakobsen CR; Schwartz TW; Mikkelsen JD
Eur J Neurosci; 1993 Dec; 5(12):1622-37. PubMed ID: 8124516
[TBL] [Abstract][Full Text] [Related]
23. Nicotine evoked improvement in learning and memory is mediated through NPY Y1 receptors in rat model of Alzheimer's disease.
Rangani RJ; Upadhya MA; Nakhate KT; Kokare DM; Subhedar NK
Peptides; 2012 Feb; 33(2):317-28. PubMed ID: 22266216
[TBL] [Abstract][Full Text] [Related]
24. Alterations in neuropeptide Y, tyrosine hydroxylase, and Y-receptor subtype distribution following spinal nerve injury to rats.
Marchand JE; Cepeda MS; Carr DB; Wurm WH; Kream RM
Pain; 1999 Feb; 79(2-3):187-200. PubMed ID: 10068164
[TBL] [Abstract][Full Text] [Related]
25. The role of Neuropeptide Y in fear conditioning and extinction.
Tasan RO; Verma D; Wood J; Lach G; Hörmer B; de Lima TC; Herzog H; Sperk G
Neuropeptides; 2016 Feb; 55():111-26. PubMed ID: 26444585
[TBL] [Abstract][Full Text] [Related]
26. Corticotropin releasing hormone neurons in the paraventricular nucleus are direct targets for neuropeptide Y neurons in the arcuate nucleus: an anterograde tracing study.
Li C; Chen P; Smith MS
Brain Res; 2000 Jan; 854(1-2):122-9. PubMed ID: 10784113
[TBL] [Abstract][Full Text] [Related]
27. Neuropeptide Y signaling modulates the expression of ethanol-induced behavioral sensitization in mice.
Hayes DM; Fee JR; McCown TJ; Knapp DJ; Breese GR; Cubero I; Carvajal F; Lerma-Cabrera JM; Navarro M; Thiele TE
Addict Biol; 2012 Mar; 17(2):338-50. PubMed ID: 21762289
[TBL] [Abstract][Full Text] [Related]
28. Central functions of neuropeptide Y in mood and anxiety disorders.
Wu G; Feder A; Wegener G; Bailey C; Saxena S; Charney D; Mathé AA
Expert Opin Ther Targets; 2011 Nov; 15(11):1317-31. PubMed ID: 21995655
[TBL] [Abstract][Full Text] [Related]
29. Subtypes Y1 and Y2 of the neuropeptide Y receptor are respectively expressed in pro-opiomelanocortin- and neuropeptide-Y-containing neurons of the rat hypothalamic arcuate nucleus.
Broberger C; Landry M; Wong H; Walsh JN; Hökfelt T
Neuroendocrinology; 1997 Dec; 66(6):393-408. PubMed ID: 9430445
[TBL] [Abstract][Full Text] [Related]
30. Galanin-neuropeptide Y (NPY) interactions in central cardiovascular control: involvement of the NPY Y receptor subtype.
Díaz-Cabiale Z; Parrado C; Rivera A; de la Calle A; Agnati L; Fuxe K; Narváez JA
Eur J Neurosci; 2006 Jul; 24(2):499-508. PubMed ID: 16903855
[TBL] [Abstract][Full Text] [Related]
31. Neuropeptide Y attenuates anxiety- and depression-like effects of cholecystokinin-4 in mice.
Desai SJ; Borkar CD; Nakhate KT; Subhedar NK; Kokare DM
Neuroscience; 2014 Sep; 277():818-30. PubMed ID: 25106129
[TBL] [Abstract][Full Text] [Related]
32. Central administration of NPY or an NPY-Y5 selective agonist increase in vivo extracellular monoamine levels in mesocorticolimbic projecting areas.
Quarta D; Leslie CP; Carletti R; Valerio E; Caberlotto L
Neuropharmacology; 2011; 60(2-3):328-35. PubMed ID: 20868698
[TBL] [Abstract][Full Text] [Related]
33. Neuropeptide Y1 and Y5 receptors mediate the effects of neuropeptide Y on the hypothalamic-pituitary-thyroid axis.
Fekete C; Sarkar S; Rand WM; Harney JW; Emerson CH; Bianco AC; Beck-Sickinger A; Lechan RM
Endocrinology; 2002 Dec; 143(12):4513-9. PubMed ID: 12446577
[TBL] [Abstract][Full Text] [Related]
34. Emerging novel roles of neuropeptide Y in the retina: from neuromodulation to neuroprotection.
Santos-Carvalho A; Álvaro AR; Martins J; Ambrósio AF; Cavadas C
Prog Neurobiol; 2014 Jan; 112():70-9. PubMed ID: 24184719
[TBL] [Abstract][Full Text] [Related]
35. Neuropeptide Y response to alcohol is altered in nucleus accumbens of mice selectively bred for drinking to intoxication.
Barkley-Levenson AM; Ryabinin AE; Crabbe JC
Behav Brain Res; 2016 Apr; 302():160-70. PubMed ID: 26779672
[TBL] [Abstract][Full Text] [Related]
36. Involvement of neuropeptide Y Y1 receptors in the regulation of neuroendocrine corticotropin-releasing hormone neuronal activity.
Dimitrov EL; DeJoseph MR; Brownfield MS; Urban JH
Endocrinology; 2007 Aug; 148(8):3666-73. PubMed ID: 17463058
[TBL] [Abstract][Full Text] [Related]
37. Neuropeptide Y Stimulates Proliferation and Migration of Vascular Smooth Muscle Cells from Pregnancy Hypertensive Rats via Y1 and Y5 Receptors.
Zhang P; Qi YX; Yao QP; Chen XH; Wang GL; Shen BR; Han Y; Gao LZ; Jiang ZL
PLoS One; 2015; 10(7):e0131124. PubMed ID: 26131716
[TBL] [Abstract][Full Text] [Related]
38. Mechanisms of neuropeptide Y, peptide YY, and pancreatic polypeptide inhibition of identified green fluorescent protein-expressing GABA neurons in the hypothalamic neuroendocrine arcuate nucleus.
Acuna-Goycolea C; Tamamaki N; Yanagawa Y; Obata K; van den Pol AN
J Neurosci; 2005 Aug; 25(32):7406-19. PubMed ID: 16093392
[TBL] [Abstract][Full Text] [Related]
39. Regulation of neuropeptide Y release by neuropeptide Y receptor ligands and calcium channel antagonists in hypothalamic slices.
King PJ; Widdowson PS; Doods HN; Williams G
J Neurochem; 1999 Aug; 73(2):641-6. PubMed ID: 10428060
[TBL] [Abstract][Full Text] [Related]
40. BODIPY-conjugated neuropeptide Y ligands: new fluorescent tools to tag Y1, Y2, Y4 and Y5 receptor subtypes.
Dumont Y; Gaudreau P; Mazzuferi M; Langlois D; Chabot JG; Fournier A; Simonato M; Quirion R
Br J Pharmacol; 2005 Dec; 146(8):1069-81. PubMed ID: 16231000
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
